Contact
Please use this form to send email to PR contact of this press release:
Mereo BioPharma and Ultragenyx Announce Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta
TO:
Please use this form to send email to PR contact of this press release:
Mereo BioPharma and Ultragenyx Announce Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta
TO: